02/07/2012 07:35:00

Glaxo, Theravance Get Positive Results From LAMA/LABA (UMEC/VI) in COPD

Related content
02 Feb - 
Adaptimmune and GSK Expand Strategic Immunotherapy Coll..

LONDON--GlaxoSmithKline PLC (GSK.LN) and Theravance, Inc. (THRX) Monday announced positive results from four pivotal phase III studies for once-daily LAMA/LABA (UMEC/VI) in COPD

MAIN FACTS:

-The results of four pivotal phase III studies of investigational LAMA/LABA involving over 4,000 patients with chronic obstructive pulmonary disease.

-These four studies include two 24-week efficacy studies that compared the combination LAMA/LABA, its components and placebo and two 24-week active comparator studies that compared the combination with the LAMA tiotropium, a widely prescribed maintenance bronchodilator for COPD.

-LAMA/LABA is a combination of two investigational bronchodilator molecules - GSK573719 or umeclidinium bromide (UMEC), a long-acting muscarinic antagonist and vilanterol, a long-acting beta2 agonist, administered by a new dry powder inhaler.

-UMEC/VI is a once-daily investigational medicine currently under development for the maintenance treatment of COPD.

-Write to Razak Musah Baba at razak.baba@dowjones.com

(END) Dow Jones Newswires

July 02, 2012 02:35 ET (06:35 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

Majedie Asset Management Ltd : Form 8.3 - Vectura Group Plc

31/05/2016 15:37:31
FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% O..

Alliance Trust PLC : Net Asset Value(s)

31/05/2016 12:51:13
ALLIANCE TRUST PLC At the close of business on Friday 27 May 2016, the unaudited net asset value per ordinary share of 2.5p, valued on a bid price basi..

Man Group PLC : Form 8.3 - Sainsbury (J) plc

31/05/2016 08:59:17
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Myriad Acquires Sividon Diagnostics
2
European Energy A/S: Financial Report Q1 2016
3
Update from the Board on clinical strategy and capital structure
4
Verisk Analytics to Present at William Blair & Company's 36th Annual Growth Stock Conference
5
Irish Continental Group plc invests €144 million to build a new cruise ferry

Related stock quotes

GlaxoSmithKline PLC 42.37 -0.9% Stock price decreasing
GlaxoSmithKline PLC 1,445.00 0.0% Stock price unchanged

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2016   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
01 June 2016 00:40:42
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20160531.2 - EUROWEB1 - 2016-06-01 01:40:42 - 2016-06-01 00:40:42 - 1000 - Website: OKAY